Abstract

Unresectable liver tumors are commonly treated with percutaneous radiofrequency ablation (RFA). However, this technique is associated with high recurrence rates due to incomplete tumor ablation. Accurate image guidance of the RFA procedure contributes to successful ablation, but currently used imaging modalities have shortcomings in device guidance and treatment monitoring. We explore the potential of using photoacoustic (PA) imaging combined with conventional ultrasound (US) imaging for real-time RFA guidance. To overcome the low penetration depth of light in tissue, we have developed an annular fiber probe (AFP), which can be inserted into tissue enabling interstitial illumination of tissue. The AFP is a cannula with 72 optical fibers that allows an RFA device to slide through its lumen, thereby enabling PA imaging for RFA device guidance and ablation monitoring. We show that the PA signal from interstitial illumination is not affected by absorber-to-surface depth compared to extracorporeal illumination. We also demonstrate successful imaging of the RFA electrodes, a blood vessel mimic, a tumor-mimicking phantom, and ablated liver tissue boundaries in ex vivo chicken and bovine liver samples. PA-assisted needle guidance revealed clear needle tip visualization, a notable improvement to current US needle guidance. Our probe shows potential for RFA device guidance and ablation detection, which potentially aids in real-time monitoring.

Highlights

  • Hepatocellular carcinoma (HCC) and colorectal liver metastases (CLM) are tumors with high occurrence in the liver [1,2]

  • The difference of this depth at different wavelengths was lower in ablated tissue. This phenomenon can be attributed to the higher scattering. These results indicate that in the first few millimeters in front of the annular fiber probe (AFP), PA signals are primarily expected to come from a circular region within the tissue, whereas at further depths, signals will originate from the entire surface filling the lumen in front of the AFP

  • The results indicate that PA signals in native liver tissue can be expected up to 7 mm from the AFP (−20 dB)

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) and colorectal liver metastases (CLM) are tumors with high occurrence in the liver [1,2]. In patients with CLM, only 10–20% of them qualify for resection [1,4]. For these unresectable cases, minimally invasive percutaneous radiofrequency ablation (RFA) is an effective outcome for tumors < 3 cm [1,3,4,5]. Minimally invasive percutaneous radiofrequency ablation (RFA) is an effective outcome for tumors < 3 cm [1,3,4,5] This technique has several benefits compared to resection: reduced morbidity, shorter hospitalization times, lower costs, and less damage to surrounding tissue [6]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call